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Abstract: The primary cilium is found in most mammalian cells and plays a functional role in tissue
homeostasis and organ development by modulating key signaling pathways. Ciliopathies are a group
of genetically heterogeneous disorders resulting from defects in cilia development and function.
Patients with ciliopathic disorders exhibit a range of phenotypes that include nephronophthisis
(NPHP), a progressive tubulointerstitial kidney disease that commonly results in end-stage renal
disease (ESRD). In recent years, distal appendages (DAPs), which radially project from the distal
end of the mother centriole, have been shown to play a vital role in primary ciliary vesicle docking
and the initiation of ciliogenesis. Mutations in the genes encoding these proteins can result in either
a complete loss of the primary cilium, abnormal ciliary formation, or defective ciliary signaling.
DAPs deficiency in humans or mice commonly results in NPHP. In this review, we outline recent
advances in our understanding of the molecular functions of DAPs and how they participate in
nephronophthisis development.
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1. Introduction
The cilium is a thin evolutionarily conserved microtubule-based organelle that pro-
trudes from the apical surface of most mammalian cell types into the extracellular space.
Although once considered to be vestigial organelles, cilia have been found to profoundly
influence tissue development and homeostasis [1–3]. Since studies of the intraflagellar
transport in the green alga Chlamydomonas in the 1990s and the discovery that cilia are
linked to renal diseases [4,5], much has been learned about the role of the cilium as a con-
duit for signal transduction pathways. Due to its receptor-enriched membrane, the primary
cilium integrates and modulates numerous signaling pathways that are critical for verte-
brate development and organ differentiation [2,6–9], including the Hedgehog (Hh) [10],
Wingless (Wnt) [11], mammalian target of Rapamycin (mTOR), G protein-coupled receptors
(GPCR) [12], platelet-derived growth factor receptor (PDGFR)-alpha [13], and transforming
growth factor (TGF)-beta and Notch pathway [14]. Moreover, cilia play important roles in
planar cell polarity and in cell cycle regulation [1,2]. Despite our improved understanding
about the relevance of cilia and an ever-increasing level of their biological functions, the
role of cilia in many cell types and organs remains poorly understood.
Cells inherit two centrioles, an older (mother) and a younger (daughter) centriole, that
serve as key components for the microtubule organizing center and as foundations for cilia.
Cilia assembly is a multi-step process that begins with anchoring of the basal body to the
plasma membrane after cells exit the mitotic cycle. These processes are mediated by the
distal appendages (DAPs) that project from the distal end of the mother centriole and dock
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to the cytoplasmic leaflet of the plasma membrane. Their molecular composition, structure,
and function in ciliogenesis have been increasingly elucidated and characterized in recent
years. To date, six proteins—CEP83, CEP89, SCLT1, CEP164, LRRC45, and FBF1—have
been defined by their distal recruitment to the mother centriole to form the core of the
distal appendages [15–18].
Defects in genes’ encoding centrosomal proteins cause an autosomal recessive disorder
characterized by dwarfism, microcephaly, and mental retardation (Seckel syndrome) [19–21],
whereas ciliary dysfunction or their absence contributes to a plethora of human diseases
presenting with highly variable clinical manifestations that have collectively been termed
“ciliopathies” [22,23]. This complex of disorders can be associated with retinal degen-
eration, cystic renal disease, obesity, liver dysfunction, skeletal deformities, congenital
heart defects, and brain developmental abnormalities [23]. Mutations in genes encoding
DAP components have been implicated in the pathogenesis of ciliopathies and reported to
exhibit ciliogenesis defects. In this review, we focus on primary cilia and ciliopathies with
particular emphasis on DAP proteins and their impact on cellular homeostasis and human
diseases.
2. Primary Cilia—Basic Structure and Molecular Composition
Ultrastructural studies resolved three subcellular main components of cilia (Figure 1A):
the basal body, a specialized centriole that anchors the cilia to the cell body; the axoneme,
a microtubule extension comprised of microtubule doublets; and the ciliary membrane,
which sheathes the axoneme [16,18].
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Figure 1. ( ). Basic structures of a pri ary ciliu . The base of the ciliu is co posed of a basal body (BB), a transition
zone (TZ), and the inversin compartment. The BB consists of a modified mother centriole that is linked to microtubules via
subdistal appendages (sDAPs) and that is tethered to the plasma membrane via distal appendages (DAPs) and transition
fibers (TFs). The non-continuous red line indicates the section of the centriole at the level of the DAPs that is shown in
Figure 1B. (B). Schematic diagram showing the arrangement of DAPs as DAP blades comprise CEP83, CEP164, SLCT1,
CEP89, and LRRC45 proteins, and the DAP matrix (DAM) includes the FBF1 protein [16]. (C). Hierarchy of assembly of the
DAPs at the base of the centriole (adapted from [15,18]). Image was created by BioRender.
The DAP proteins have been found to play an important role in the initial steps
of ciliogenesis [24–26]. Cilia assembly starts when cells exit the cell cycle and become
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quiescent or differentiate. The transition from the centriole to the basal body is initiated by
the accumulation and fusion of Golgi-derived cytoplasmic vesicles to the distal appendages
of the mother centriole generating the primary ciliary vesicle. The vesicle then migrates to
the cell surface and anchors to the plasma membrane through the distal appendages. After
docking to the cell membrane, the transformation into the basal body is completed [27]. The
basal body, which consists of nine triplet microtubules, remains connected to the daughter
centriole, and functions as the microtubule-organizing center for the cilium [24–26].
Distal of the basal body the transition zone is assembled, which acts as a selective
barrier making the ciliary compartment biochemically distinct from the rest of the cell. This
barrier is established by the transition fibers and by the Y-shaped fibers or ‘Y-linkers’. The
transition fibers connect the basal body to the ciliary membrane through the centriolar ap-
pendages, whereas the Y-linkers connect the ciliary membrane to the underlying axoneme.
Both structures organize the diffusion barrier for membrane-associated soluble proteins
regulating their ciliary entry and exit. The transition fibers may also serve as a docking site
for intraflagellar transport (IFT) proteins [28].
The ring of nine microtubules triplets of the basal body form a template for the ring
of nine microtubule doublets of the ciliary axoneme. The biological basis of converting
triplets to doublets between the basal body and the axoneme remains unknown. The
microtubules are composed of alpha- and beta-tubulin, which has been post-translationally
modified to stabilize it from depolymerization. The axonemal microtubule-based structure
confers the function of the cilium as either a motile cilium or non-motile (primary) cilium.
In contrast to primary cilia, motile cilia possess an extra central microtubule pair. This
“9 + 2” arrangement and the presence of specialized motor proteins enable ciliary motility
to create coordinated beating patterns. Motile cilia are present in multiple copies per
cell and are found on airway epithelial cells, oviduct cells, and ependymal cells in the
brain. Interestingly, nodal cilia also lack the central microtubules, but possess ciliary motor
proteins allowing them to generate a rotary motion that is required for body patterning [29].
The ciliary membrane sheathes the axoneme and is connected by the Y-linkers of the
transition zone. Although the ciliary membrane is continuous with the plasma membrane it
possesses a unique lipid composition and is highly enriched for specific signaling molecules,
including transmembrane receptors and signaling phosphoinositides. This structural
and physiological composition supports the mechano-sensory ciliary function and its
participation in the signal transduction of several molecular pathways.
As cilia lack their own protein synthesis machinery all components need to be trans-
ported to the cilia via specialized transport processes. Ciliary assembly and maintenance
rely on a polarized trafficking system from the Golgi apparatus and the endocytic recycling
compartment to the basal body mediated by small GTPases of the Rab family. Rab8 and
its activator Rabin8 are essential for the entry of protein cargoes into the ciliary compart-
ment. Targeting of Rabin8 to the ciliary base is regulated by Rab11. Recently, it has been
demonstrated that PtdIns3P selectively produced in the endocytic recycling compartment
promotes activation of Rab11a, triggering the translocation of proteins to the primary cil-
ium [30,31]. The bi-directional cargo transport along the axoneme is provided through the
intraflagellar transport (IFT) system [32]. The kinesin-2 motor-IFT B complex enables the
anterograde shuttle from the basal body to the tip, while dynein-IFT A protein complexes
coordinate the retrograde transport [33,34].
The critical role of distal appendages in membrane docking to initiate ciliogenesis
is based on various functions. Distal appendages are required to remove the ciliogen-
esis inhibitor CP110 from the mother centriole by recruiting the Tau tubulin kinase 2
(Ttbk2) [15,18]. Furthermore, the distal appendage protein CEP164 regulates ciliary-
directed vesicular transport through its interaction with Rab8 and Rabin8 [35]. At least six
proteins are required for the establishment of the distal appendages ensemble: centrosomal
protein 83 (CEP83), centrosomal protein 164 (CEP164), centrosomal protein 89 (CEP89),
sodium channel and clathrin linker 1 (SCLT1), Fas binding factor 1 (FBF1), and leucine rich
repeat containing 45 (LRRC45) [15,18]. The disruption of the DAP complex results in an
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impaired ciliary assembly and mutations in genes encoding DAP proteins are characterized
by phenotypes affecting various organs associated with ciliopathies [36–41].
Super-resolution microscopy studies revealed that DAPs are organized in a conical-
shaped architecture, which interfaces the centriole and cilium, and the plasma and ciliary
membranes. CEP83, CEP89, SCLT1, and CEP164 form the backbone of the radially localized
core DAP components, exhibiting a symmetric ring-like pattern [15]. At the root of the
windmill-like blades is CEP83, while CEP164 is extended at the tip near the docking site
of the membrane (Figure 1B). The gap between adjacent blades is filled with the distal
appendage matrix (DAM) containing the core IFT complex component IFT88, the small
GTPase ARL13B, and FBF1 [16,18]. Since FBF1 is associated with the proximal junction of
the ciliary pocket, a hotspot of ciliary endo- and exocytosis, FBF1 may serve as a barrier
to gate the ciliary compartment. The assembly of DAPs occurs in a hierarchical sequence
(Figure 1C) [15]. CEP83 and SCLT1 regulate the recruitment of CEP164 and LRRC45 [15,18].
LRRC45 localizes to the distal appendage of the mother centriole as part of the appendage
blade complex and aids FBF1 into the matrix between the blades.
More recent data support the presence of a distal centriole complex, which is required
to assemble the distal appendages. The complex consists of three proteins, MNR, OFD1,
and CEP90. MNR forms the innermost ring at the distal centriole and recruits OFD1,
together with CEP90 [42]. CEP90 is a key component of the centriolar satellites and of the
distal end of centrioles. CEP90 regulates mother centriole function and recruits CEP83 to
initiate distal appendage assembly at the mother centriole [42].
3. The Genetic Basis of Nephronophthisis (NPHP) and Related Disorders
The term nephronophthisis-related ciliopathies (NPHP-RC) summarizes a group of
autosomal-recessive cystic kidney diseases, including nephronophthisis (NPHP), Senior–
Løken syndrome (SLS), Joubert syndrome (JBTS), and Meckel–Gruber syndrome (MKS) [23].
NPHP-RC are genetically heterogeneous disorders, caused by mutations in genes encoding
proteins that localize to primary cilia, basal bodies, or centrosomes. Their disruption leads
to structurally or functionally aberrant cilia, resulting in a broad phenotypic spectrum,
which is collectively termed “ciliopathies” [23,43]. NPHP-RC represent the most frequent
monogenic cause of kidney disease in children and young adults that progress to kidney
failure within the first three decades of life [44,45]. Commonly, NPHP-RC are accompanied
by multiple extra-renal organ manifestations such as retinal degeneration or periportal
liver fibrosis [46].
NPHP-RC are considered rare disorders with varying incidences of 0.1–0.2 per 10,000 live
births [47–49]. However, the overall prevalence of NPHP-RC is likely to be an underesti-
mation. Recent studies indicate that NPHP is a relatively frequent cause of end-stage renal
disease (ESRD) in adults [50]. The traditional classification of NPHP is based on the age of
onset, distinguishing three forms of progression—infantile, juvenile, and adolescent/adult.
The juvenile form is most common and also referred to as classic NPHP. The median age
of progression to ESRD is <4 years for infantile NPHP, 13 years for juvenile NPHP, and
19 years for adolescent NPHP [45].
The initial clinical symptoms of NPHP are typically mild and often nonspecific, in-
cluding polyuria with secondary enuresis and polydipsia due to urinary concentrating
defects. In contrast to other kidney diseases affected individuals usually do not develop
severe hypertension [51]. The most prominent renal features are increased echogenicity
and corticomedullary cysts with normal or small-sized kidneys on renal ultrasound [44,52].
Hallmarks of NPHP in renal histology are thickening and disintegration of the tubular
basement membrane, interstitial fibrosis and tubular atrophy, and cyst formation [53], as
shown in Figure 2. Corticomedullary cysts are recorded in 70% of patients with juvenile
NPHP [54]. Electron microscopy may reveal tubular basement membrane duplication
and thickening. It should be noted that another rare kidney disease, autosomal dominant
tubulointerstitial kidney disease (ADTKD), shares similar histological features. Therefore,
the histopathological diagnosis is superseded by the genetic diagnosis.
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About 15% of the affected individuals with NPHP-RC exhibit extrarenal manifesta-
tions. Its recognition is important and may allow defining a clinical diagnosis. The most
n table extrarenal man festatio , retinal degeneration, occurs 10% of all patients with
NPHP and is defined as Senior–Løke syndrome (SLS) [55–57]. Cerebellar malformations
such as cerebellar vermis hypoplasia/aplasia are commonly observ d in individuals with
Joubert syndrome (JBTS) [58,59], characterized by the “mo ar tooth sign” brain imaging
st dies [60]. These malformations e associated with developmental delay, intellectual
disability, muscle hypot nia, ataxia, and oculomotor apraxia. Meckel–Gruber syndrome
(MKS) represents t e most severe manifestati n due to extreme multiorgan involvement
that often results in perinatal lethality [61]. Bar et–Biedl syndrome (BBS) is a complex,
genetically heterogeneous disorder that affects numerous organ systems. Mutations in 19
different genes have been described as causative, leading to intellectual disability, obesity,
cystic kidney disease, retinitis pigmentosa, and polydactyly [62,63].
To date, up to 90 genes have been implicated in the pathogenesis of NPHP-RC, and
mutations in 25 of these genes cause NPHP [49]. Many of the gene products participate in
functional protein complexes, which localize to primary cilia or to centrosomes. Pathogenic
variants in these genes lead to variable defects [56], resulting in clinical symptoms such as
retinal, kidney, and neurodevelopmental defects, as well as early lethality, summarized as
ciliopathies [46].
Mutations in NPHP1 are the most common cause of NPHP (MIM 256100), accounting
for 20–25% of all cases. About 85% of these cases are based on homozygous full gene
deletions of the NPHP1 gene, which have also been identified in affected individuals with
SLS (MIM 266900), and very rarely in those with JBTS (MIM 609583). Interestingly, a
recognizable genotype–phenotype relationship has not been detected. The gene product,
nephrocystin-1 localizes to adherens junctions, focal adhesions, and to the ciliary transition
zone. Although deletions in NPHP1 have already been described in 1997, the patho-
physiological mechanisms by which NPHP1 disruption leads to NPHP remain unknown.
Moreover, the physiological function of Nephrocystin-1 is uncertain. However, high-
confidence proteomic [64] and proximity-dependent biotinylation studies have shown that
Nephrocystin-1 interacts directly with other NPHP proteins [65]. Thereby, the ciliary pro-
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teins form an interaction network, which can be classified into three biochemically distinct
modules: (1) the NPHP1-4-8 module; (2) the NPHP5-6 module; and (3) the MKS complex.
The NPHP1-4-8 module, consisting of NPHP1, NPHP4, and NPHP8, localizes to
the ciliary transition zone and may play a role in epithelial morphogenesis and in the
establishment of tissue architecture. Mutations in NPHP4 have been identified in af-
fected individuals diagnosed with juvenile NPHP (MIM 606966) and SLS (MIM 606996).
Interestingly, NPHP4 has been shown to regulate Hippo signaling through promoting
phosphorylation and nuclear shuttling of YAP/TAZ [66]. Furthermore, NPHP1 directly in-
teracts with NPHP3, which localizes to the Inversin compartment (IC) within the proximal
cilium [67]. The IC consists of at least three additional proteins: Inversin/NPHP2 (INVS),
Serine/threonine-protein kinase NEK8/NPHP9, and ANKS6/NPHP16 [68]. Pathogenic
gene variants encoding proteins of the IC cause a spectrum of overlapping phenotypes in
humans and rodent models, including cystic kidney disease, cardiovascular abnormalities,
and periportal liver fibrosis [68–74]. Although its assembly hierarchy is characterized, and
a link to Wnt and Hippo-signaling established, the role of IC-mediated signaling events
remains incompletely understood [68–73]. NPHP8/RPGRIP1L controls the assembly of the
ciliary transition zone and regulates the ciliary gating function [75]. Consequently, its defi-
ciency leads to an altered ciliary protein composition [76]. Moreover, RPGRIP1L regulates
the proteasomal activity at the primary cilium by interacting with Psmd2, a component
of the regulatory proteasomal 19S subunit [77]. In addition, RPGRIP1L has been shown
to be essential for Hedgehog signaling responsiveness and to regulate mTOR-mediated
autophagic activity [78,79]. Mutations in NPHP8 lead to severe ciliopathies, including MKS
(MIM 611561) and JBTS (MIM 611560) [80].
The NPHP5-6 module encompasses NPHP5 and NPHP6 and localizes to the cen-
trosome. Mutations in NPHP5/IQCB1 cause a retinal–renal phenotype characterized by
retinitis pigmentosa with NPHP [55]. The binding partner, NPHP6/CEP290, is one of
the most intriguing NPHP-RC-associated disease genes. So far, more than 100 different
mutations in CEP290 have been identified, causing a broad variety of distinct phenotypes,
including SLS (MIM 610189), JBTS (MIM 610188), and MKS (611134) [81]. The subcellular
localization of CEP290 is regulated in a cell cycle-dependent manner. In quiescent cells,
CEP290 is an integral component of the ciliary transition zone, whereas is in dividing cells it
localizes to the distal mother centriole [82]. A potential role for NPHP5/NPHP6 in primary
cilium assembly was established by identifying CEP290 as essential for targeting Rab8a,
which is required for ciliary growth through the initiation of intraciliary and vesicular
trafficking [82].
The MKS module includes MKS1 and its interacting proteins, which localize to the
base of the cilium. This complex is characterized by its connection to Hedgehog signaling-
mediated neural tube development and binds Tectonic2 (TCTN2) [67,83]. Mutations in
genes encoding for proteins of this complex lead to MKS (MIM 249000) [84], a severe
pleiotropic autosomal recessive developmental disorder characterized by developmental
defects of the central nervous system that include neural tube defects.
Although nephronophthisis-related ciliopathies (NPHP-RC) are among the most fre-
quent monogenic causes of kidney disease during the first three decades of life, therapeutic
options are almost nonexistent. As a result, patients are at a greatly heightened risk
of kidney failure and requirement of renal replacement therapy. Despite our improved
understanding about the relevance of cilia, an ever-increasing number of established
ciliopathy-associated genes and improved genetic diagnostics, the pathomechanisms un-
derlying NPHP-RC remain incompletely characterized. This highlights the urgent need to
explore the underlying disease mechanisms and to identify new therapeutic targets.
4. Molecular Functions of DAPs in Ciliogenesis
Cilia are observed primarily in quiescent or differentiated cells in both developing
and adult tissues. Ciliogenesis is coupled to the cell cycle and occurs from the distal end
of the mother centriole as cells exit the mitotic cycle at the G1/G0 phase [85]. Ciliary
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assembly is an elaborately regulated process involving various cellular machineries and
signaling pathways. Ciliogenesis starts with the docking of the basal body to the plasma
membrane, tightly mediated by the distal appendages (DAPs) of the mother centriole that
involves the orchestrated recruitment of six DAP proteins [86]. In addition to anchoring the
mother centriole to the cellular membrane, DAPs also play essential roles in recruitment of
TTBK2, in Rab8a-targeted vesicle trafficking, and in centriolar satellite organization [18]
(Figure 3). Furthermore, DAPs create a border between the plasma membrane and the
ciliary membrane, thus functioning—together with nucleoporins and the ciliary transition
zone—as a gate enabling the selective translocation of proteins into the ciliary compartment.
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membranes are extended, and the axoneme is elongated, leading to (6) the completion of cilium formation. Image was 
created by BioRender. 
Cilia formation starts when Golgi- and recycling endosome-derived vesicles, termed 
distal appendage vesicles, accumulate in proximity to the distal appendages and dock to 
the mother centriole [87]. These vesicles then fuse, forming the primary ciliary vesicle 
(PCV), mediated by EHD1 and SNAP29 [88,89]. Following assembly of the PCV, Tau Tu-
bulin Kinase 2 (TTBK2) is recruited, which allows to remodel the distal ends of the basal 
bodies by removing the CP110–CEP97 complex. CP110 ‘caps’ the basal body and functions 
as a negative regulator of ciliary extension and as a checkpoint against inappropriate cilia 
formation. Vesicular transport to the centrosome includes the recruitment of the 
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primary ciliary vesicles (PCVs) form from smaller DAVs (facilitated by EDH1 and SNAP29 proteins). (4) Recruitment of
TTBK2 and removal of the inhibitory CP110–CEP97 complex. (5) Rab8-positive vesicle docks at the centrosome, membranes
are extended, and the axoneme is elongated, leading to (6) the completion of cilium formation. Image was created
by BioRender.
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negative regulator of ciliary extension and s a heckpoint agai st inappropriate
cilia formation. Vesicul r transport to the centr some includes the recruitment f t
Rab11/Rab8/Rabin8 complex, which promotes cilia membrane biogenesis. Rab8 and its
activator, Rabin8, are fundamental for the transport and entry of proteins into the ciliary
compartment. Targeting of Rabin8 to the ciliary base is regulated by the Rab GTPase
Rab11, a coordinator of endosome recycling to the plasma membrane. At the ciliary
base, Rab11 directly associates with Rabin8 mediating the guanine nucleotide exchange of
Rab8 [90,91]. Additionally, the IFT machinery coordinates the bidirectional transport of the
ciliary proteins along axonemal microtubules during cilia assembly and maintenance [92].
DAPs also play a critical role in centriolar satellite organization, which is essential for
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TZ establishment and positioning of Rab8 vesicles at the mother centriole upon cilia
formation [93–95] (Figure 3).
Dysfunction of the distal appendages causes diverse developmental disorders in
humans and animal models. Since DAPs are key components of microtubule-organizing
center and provide the foundation for ciliary assembly, deficient or defective DAP proteins
are associated with disrupted ciliogenesis and alterations in the cilia-related signaling
pathways. To date, human mutations have been reported in three genes encoding DAPs
proteins (CEP83, CEP164, and SCLT1) and in CEP90, which recruits the proximal-distal
appendage component CEP83. Various genetic studies of model systems such as mutant
mouse models emphasize that DAP deficiency is associated with the pathogenesis of
ciliopathies. In the following sections, we will review the detailed function of the six DAP
proteins for cilia assembly and their implication in disease development of NPHP-RC.
4.1. CEP83/CCDC41/NPHP18
CEP83 is the most proximal DAP protein, recruited by CEP90 to initiate distal ap-
pendage formation [16]. Loss of CEP83 in retinal pigment epithelial cells (RPE-1) and
murine inner medullary collecting duct (IMCD3) cells prevents the recruitment of all
other DAP components but does not affect their expression levels. In cells lacking CEP83,
the primary ciliary vesicle fails to anchor to the mother centriole, leading to defective
initiation of ciliogenesis [15,96,97]. This indicates that CEP83 is essential to initiate cilia
formation. Interestingly, studies on human telomerase-immortalized retinal pigment ep-
ithelial cells (hTERT-RPE1) have demonstrated that TTBK2-mediated phosphorylation of
CEP83 regulates ciliary vesicle docking and CP110 removal. CP110 removal also depends
on the degradation of M-Phase Phosphoprotein 9 (MPP9), a substrate of TTBK2 [98,99].
TTBK2-dependent MPP9-phosphorylation enhances its degradation, which promotes cilia
initiation. It has further been shown that MPP9 degradation and subsequent CP110 removal
depend on the recruitment of a cilia-specific E3 ligase to the mother centriole [99]. This pro-
cess is accompanied by TTBK2-dependent CEP83 phosphorylation and changing of CEP83
conformation (Figure 4A) [97]. MPP9 is recruited to the distal end of the mother centriole
by the Kinesin Family Member 24 (KIF24), enhancing the recruitment of CP110–CEP97 by
binding to CEP97. Morpholino-mediated knockdown of the CEP83 ortholog Ccdc41 in
zebrafish leads to olfactory ciliogenesis defects. The removal of CEP83 from radial glial
progenitor cells in mice disrupts the anchorage of the centrosome abolishing cilia formation
and leads to an excessive proliferation with an enlarged cortex formation, and activation of
the Hippo signaling key effector protein YAP [96].
In humans, recessive mutations in CEP83 (OMIM 615847) were identified as the molec-
ular cause for Nephronophthisis-18 (NPHP18; MIM 615862) [36]. To date, nine patients
from eight independent families with homozygous or compound heterozygous mutations
in the CEP83 gene have been reported. Five affected individuals carried compound het-
erozygous mutations composed of a missense mutation and either an in-frame deletion or
a protein truncating mutation. Three families with homozygous mutations have been iden-
tified: One with a missense, one with an in-frame deletion, and one carrying a truncating
mutation. All affected individuals showed an early-onset nephronophthisis resulting in
end-stage renal disease at 1 to 4 years of age. Different histological alterations of the kidney
were described in individuals with CEP83 mutations [36]. Three individuals displayed
microcystic tubular dilatations, one individual had glomerular cysts and glomeruli dys-
plasia, and two individuals had abnormal thickness of the tubular basement membranes.
Interstitial fibrosis was observed in five patients. Extra-renal manifestations, including
neurological alterations, such as intellectual disability, and/or hydrocephalus, have been
detected in four individuals with CEP83 mutations [36], as referred in Table 1. Two individ-
uals presented with periportal liver fibrosis. The most severe phenotype has been observed
in one affected individual with a homozygous truncating mutation of CEP83 accompanied
by triple X syndrome and included ESRD, facial dysmorphism, and heart anomalies [36].
Patient-derived fibroblasts from two individuals carrying one truncating mutation in trans
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with either a missense or an in-frame variant showed a decreased percentage of ciliated
cells and an altered subcellular distribution of CEP164, while the localization of CEP89
remained unaffected. CEP83 mutants that represented mutations, leading to a truncated
protein or to an in-frame deletion of amino acids in the coiled-coil domains of CEP83, failed
to localize to the centrosome and accumulated in the nuclei when transfected into RPE1
cells. Furthermore, these CEP83 mutants failed to interact with CEP164 and IFT20. In
contrast, missense variants of CEP83 and in-frame deletions outside the coiled-coil domains
did not display defects of centrosomal localization.




Figure 4. The role of DAPs in ciliogenesis. (A). CEP83 recruits E3 ligase and phosphorylates TTBK2 to remove the CP110–
CEP97 complex and induce MPP9 degradation. (B). CEP164 has three roles: (1) the formation of the CEP164–Cby complex 
to recruit TTBK2; (2) the recruitment of EDH1 to enhance PCV formation; and (3) the interaction with Rabin8 to activate 
Rab8. (C). LRRC45 and CEP89 organize centriolar satellites. CEP89 plays a direct role in EDH1 recruitment. (D) FBF1 
regulates the lateral diffusion of the IFT complex. Image was created by BioRender. 
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lecular cause for Nephronophthisis-18 (NPHP18; MIM 615862) [36]. To date, nine patients 
from eight independent families with homozygous or compound heterozygous mutations 
in the CEP83 gene have been reported. Five affected individuals carried compound heter-
ozygous mutations composed of a missense mutation and either an in-frame deletion or 
a protein truncating mutation. Three families with homozygous mutations have been 
identified: One with a missense, one with an in-frame deletion, and one carrying a trun-
cating mutation. All affected individuals showed an early-onset nephronophthisis result-
ing in end-stage renal disease at 1 to 4 years of age. Different histological alterations of the 
kidney were described in individuals with CEP83 mutations [36]. Three individuals dis-
played microcystic tubular dilatations, one individual had glomerular cysts and glomeruli 
dysplasia, and two individuals had abnormal thickness of the tubular basement mem-
branes. Interstitial fibrosis was observed in five patients. Extra-renal manifestations, in-
cluding neurological alterations, such as intellectual disability, and/or hydrocephalus, 
have been detected in four individuals with CEP83 mutations [36], as referred in Table 1. 
Two individuals presented with periportal liver fibrosis. The most severe phenotype has 
been observed in one affected individual with a homozygous truncating mutation of 
CEP83 accompanied by triple X syndrome and included ESRD, facial dysmorphism, and 
heart anomalies [36]. Patient-derived fibroblasts from two individuals carrying one trun-
cating mutation in trans with either a missense or an in-frame variant showed a decreased 
percentage of ciliated cells and an altered subcellular distribution of CEP164, while the 
localization of CEP89 remained unaffected. CEP83 mutants that represented mutations, 
leading to a truncated protein or to an in-frame deletion of amino acids in the coiled-coil 
domains of CEP83, failed to localize to the centrosome and accumulated in the nuclei 
when transfected into RPE1 cells. Furthermore, these CEP83 mutants failed to interact 
with CEP164 and IFT20. In contrast, missense variants of CEP83 and in-frame deletions 
outside the coiled-coil domains did not display defects of centrosomal localization. 
Figure 4. The role of DAPs in ciliogenesis. (A). CEP83 recruits E3 ligase and phosphorylates TTBK2 to remove the CP110–
CEP97 complex and induce MPP9 degradation. (B). CEP164 has three roles: (1) the formation of the CEP164–Cby complex to
recruit TTBK2; (2) the recruitment of EDH1 to enhance PCV formation; and (3) the interaction with Rabin8 to activate Rab8.
(C). LRRC45 and CEP89 organize centriolar satellites. CEP89 plays a direct role in EDH1 recruitment. (D) FBF1 regulates
the lateral diffusion of the IFT complex. Image was created by BioRender.
Table 1. Summary of the current knowledge of DAP genes in relation to human molecular genetics, includi g its phenotypic
description and available animal model .
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Note: Hs, Homo sapiens; Mm, Mus musculus; Dr, Danio rerio.
4.2. CEP164/NPHP15
CEP164 localizes in a cell cycle-dependent manner to the mother centriole and to
mitotic spindle poles [16]. Super-resolution studies revealed that CEP164 comprises part of
the backbone structure of the DAP blades [16]. Its recruitment to the centriole depends on
CEP83 and SCLT1. Depletion of CEP164 in mammalian cells leads to the reduced anchorage
of the mother centriole to the membrane and failed targeting of Rab8a to the centrosome
abolishing cilia formation [15,109,110]. This implies a model where CEP164 binds to
the Rab8a/Rabin complex, promotes the accumulation of Rab8 at the centrosome, and
regulates the docking of Golgi-derived vesicles to the distal appendages [110,111]. Indeed,
the proper centriolar migration and docking depends on the formation of a CEP164/Rabin8
complex, enhanced by the coiled protein Chibby (Cby). After binding to CEP164, Cby
recruits Rabin8, thereby promoting the formation of the CEP164/Rabin8 complex that
leads to polarized transport and fusion of Rab8-positive vesicles to ensure maturation of
ciliary vesicles, which enables the anchorage of the basal body to the apical membrane
(Figure 4B) [111]. Moreover, CEP164 recruits TTBK2, which triggers ciliogenesis through
targeting IFT components and releasing CP110 from the mother centriole [112].
CEP164 deficiency has also been associated with an impaired DNA damage response
(DDR) and altered cell cycle checkpoint control. In hTERT-RPE cells, CEP164 localizes to
the nucleus in proximity with DDR proteins, such as SC-35 (a splicing factor), checkpoint
kinase 1 (CHK1), and Tat-interactive protein 60 (TIP60) [102], and interacts with the cell
cycle checkpoint proteins ataxia telangiectasia mutated (ATM) and ataxia telangiectasia
and Rad3-related protein (ATR) during activated DDR signaling. Accordingly, depletion
of cep164 in zebrafish causes sensitivity to DNA damage as evidenced by an increased
expression of phosphorylated γH2AX [102]. Moreover, CEP164 deficiency leads to a
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delayed S-phase progression and an abrogation of the G2/M checkpoint, suggesting an
essential role in cell cycle regulation. IMCD3 cells depleted of Cep164 show evidence of
apoptosis and epithelial-to-mesenchymal transition (EMT) [39].
Human recessive mutations in CEP164 (OMIM 614848) lead to Nephronophthisis-15
(NPHP15; MIM 614845) [102,103] and presumably to Bardet–Biedl syndrome [104] and
primary ciliary dyskinesia (PCD) [105]. Four affected individuals have been reported
with homozygous truncating mutations in CEP164, and one with a homozygous missense
mutation. Furthermore, two individuals displayed compound heterozygous mutations
consisting of a truncating mutation in trans with a missense variant or two missense mu-
tations. While hypomorphic mutations lead to NPHP and Senior–Løken syndrome, null
mutations have been reported to cause a more severe dysplastic phenotype of Meckel
syndrome and Joubert syndrome, as shown in Table 1. The overexpression of CEP164 con-
structs, which mimic two of the detected truncating mutations in IMCD3 cells, abrogated
the subcellular localization of CEP164 at the mother centriole. In contrast, the transfection
with constructs reflecting two of the missense mutations showed a proper centrosomal
localization of CEP164 in hTERT RPE-1 cells but lead to diminished cilia formation. Interest-
ingly, these constructs also compromised the interaction with TTBK2 through an impaired
folding of the N-terminal domain of CEP164 [113]. The impaired S-phase progression
upon depletion of CEP164 in IMCD3 cells cannot be rescued through the overexpression
of two different disease-associated cDNA-constructs that mimics a nonsense and a mis-
sense human mutation. Furthermore, the transfection of the same nonsense CEP164 allele
induced epithelial-to-mesenchymal transition and an increased expression of pro-fibrotic
genes [39]. The knockdown of cep164 in zebrafish embryos mimics ciliary phenotypes,
including laterality defects, pronephric tubule cysts, and retinal dysplasia [102]. Global
Cep164 deficiency in mice leads to early embryonic lethality due to holoprosencephaly,
cardiac looping defects, and a truncated posterior trunk [106]. A collecting duct-specific
deletion of Cep164 abolishes ciliogenesis and leads to a dysregulated cell cycle and epithelia
cell hyperproliferation that drives renal cyst growth [40]. Interestingly, treatment of these
mutant mice with a cyclin-dependent kinase inhibitor reduces cortical cyst formation and
epithelial proliferation, restoring normal cortical histology [40]. Depletion of Cep164 in
multiciliated cells of FOXJ1-positive tissues results in hydrocephalus and perturbs the
differentiation of multiciliated cells in murine airway and oviduct epithelia [106].
It remains unclear whether the ciliary or nuclear dysfunction predominantly accounts
for the renal and extra-renal disease development in individuals with deficient CEP164.
Considering the phenotypic overlap with affected individuals carrying mutations in other
NPHP-RC-associated genes whose products localize in different ciliary compartments
lacking a nuclear localization, it is tempting to speculate that the ciliary dysfunction pri-
marily determines the underlying pathogenesis [26]. However, it should also be noted
that many cilia proteins have extra-ciliary functions, such as cell cycle regulation [114,115].
Therefore, one can hypothesize that, independently of the ciliary dysfunction and pre-
sumably dependent on genotype, the nuclear dysfunction of CEP164 promotes disease
progression through an altered cell cycle regulation and DDR response, thus explaining
the phenotypically heterogeneity [102]. Further functional studies are needed to address
these hypotheses.
4.3. CEP89/CCDC123/CEP123
CEP89 localizes to the distal end of the centriole within the appendage blade complex
recruited through CEP83, independently of SCLT1 [16]. Depletion of CEP89 in RPE-1
cells results in disrupted ciliary vesicle formation and failed docking to the distal mother
centriole, leading to defective ciliogenesis [15,116]. CEP89 interacts with the centriolar
satellite proteins PCM-1 (pericentriolar material 1), OFD1 (oral-facial-digital syndrome 1),
BBS4 (Bardet–Biedl Syndrome 4), and CEP290 (Centrosomal protein 290) [116] (Figure 4C).
PCM-1 and CEP290, in turn, interact physically and functionally, recruiting the small GT-
Pase Rab8a, a key regulator of vesicle trafficking. Rab8a mediates the membrane-trafficking
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to centrosomes and cilia, promotes anchorage and fusion of membranous vesicles for cilia
assembly, and is required for ciliary elongation and maintenance [117,118]. A more recent
systematic mapping of the centrosome–cilium interface confirmed this protein network
and showed that the poorly studied peptide C3orf14 also interacts directly with CEP89 [65].
Further studies on mouse 3T3 cells have demonstrated that the interacting partners CEP290
and Rab8a form a distinct complex complemented by CP110, which antagonizes the ac-
tivity of CEP290 and prevents CEP290-dependent Rab8a ciliogenesis [119]. It is therefore
tempting to speculate that CEP89 may also play a critical role in migration and insertion
of mother centrioles into the plasma membrane, implementing cilia assembly. Further
evidence for this participation comes from the association with PCM-1, a central scaffold
for the binding of centriolar satellite proteins. PCM-1 depletion leads to impaired primary
cilia formation. In addition, PCM-1 organization is impaired in cells lacking CEP89. Inter-
estingly, deficiency in OFD1 and BBS4 also results in diminished ciliogenesis [120] through
disrupted distal appendage formation, impaired centriole elongation [121], and PCM-1
mislocalization [122].
4.4. LRRC45
LRRC45 is also part of the appendage blade complex, localizes to the proximal end of
both the mother and daughter centrioles, and is associated with the basal body of primary
and motile cilia [18,123]. LRRC45 is recruited to the centriole by CEP83 and SCLT1. LRRC45
is needed to shuttle FBF1 into the distal appendage matrix [18]. Consequently, the depletion
of LRRC45 leads to decreased levels of FBF1 at the mother centrioles [18]. RPE-1 cells lack-
ing LRRC45 show an impaired cilia formation, indicating that LRRC45 is needed for cilia
assembly and elongation [18]. Further studies have demonstrated that LRRC45 is necessary
for cilia-directed trafficking and docking of Rab8-postive vesicles—similar to the presumed
function of CEP89, but not for the Cep164/TTBK2-dependent removal of the CP110–Cep97
complex [18]. LRRC45 also plays a critical role in organizing centriolar satellite proteins,
including PCM-1 and SSX2IP, the latter promoting centrosome maturation [18]. Additional
studies on HeLa and U2OS cells indicate that LRRC45 functions as a centrosome linker,
and its depletion leads to centrosome splitting during the interphase [123].
4.5. FBF1
FBF1 is recruited to the centriole by SCLT1. FBF1 localizes within the distal appendage
matrix between the appendage blades in close proximity to the ciliary membrane [15–17].
FBF1 depletion in RPE-1 cells results neither in an impaired CP110-TTBK2 recruitment
nor in defective ciliogenesis [18]. It is hypothesized that FBF1 plays a critical role in
ciliary gating and arranging the ciliary composition. This is supported by the reduced
distribution of IFT88 in the DAM, leading to a mislocalization of ciliary transmembrane
proteins. In agreement, studies on the C. elegans homolog dyf-19 have demonstrated a
regulatory function of FBF1 for the entry and transit of IFT particles into the cilium [124,125]
(Figure 4D). Similar to LRRC45, the depletion of FBF1 results in a satellite disorganization,
as evidenced by a decreased concentration of the proteins PCM1 and SSX2IP [18].
4.6. SCLT1
SCLT1 belongs to the backbone of the pinwheel-like DAP blades and is required for
the recruitment of CEP164, FBF1, and LRRC45 to centrioles [15–18]. Depletion of SCLT1 in
cultured RPE1 cells results in a lack of cilia formation [15]. Likewise, loss of Sclt1 in mice
leads to disrupted cilia assembly, causing polydactyly and renal cyst formation, including
an increased proliferation and apoptosis rate in murine tubular epithelial cells [38]. Further
studies have demonstrated that Sclt1 deficiency promotes ERK signaling through the
PC2/cAMP/PKA axis and activates the STAT3 and TGF-β/SMAD pathways in renal
epithelial cells [38]. Consistently, the cystic kidney phenotype could be partially rescued
by the administration of a STAT3 inhibitor [38]. Interestingly, similarly to Cep164 loss
of function, cyst growth in the kidney has been attributed to tubular hyperproliferation
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along with increased expression levels of cell cycle markers. Furthermore, and equivalent
to the other members of the DAP complexes, SCLT1 plays a critical role in centriolar
satellite organization, since SCLT1 depletion in RPE-1 cells alters the expression levels of
the centriolar satellites proteins PCM-1 and SSX2IP [18].
In humans, compound heterozygous mutations in SCLT1 (OMIM 611399) have been
detected in an affected individual diagnosed with Senior–Løken syndrome. Both variants
located at the exon–intron boundaries and have demonstrated to generate an aberrant
splicing transcript [37]. In addition, one homozygous splice site mutation causing a protein
truncating product has been reported in one individual diagnosed with orofaciodigital
syndrome (OFD IX, MIM 258865) who presented with midline cleft, microcephaly, choanal
atresia, and coloboma, as well as congenital heart involvement [107]. Compound het-
erozygous pathogenic missense variants were detected in two independent individuals
with Bardet–Biedl syndrome, who presented with renal dysfunction, intellectual disability,
short stature, and truncal obesity [108], as summarized in Table 1. It remains unclear to
what extent the reported mutations affect the function and localization of the SCLT1 gene
products. Based on the genetic findings, a loss of function can be assumed for the affected
individuals with SLS and OFD IX.
4.7. CEP90/PIBF1
CEP90 has been identified as a component of centriolar satellites and previously
as part of the distal centriole complex (DISCO) [126], which serves as a foundation for
DAP formation. CEP90 is essential for spindle pole integrity, and for the recruitment
of CEP63 as well as of CDK2, a cyclin-dependent kinase with well-known functions for
cell cycle progression and centriole duplication [127]. Furthermore, CEP90 interacts with
centriolar satellite protein PCM1, which delivers proteins to the centrosome and with MNR
and OFD1 [128]. Together with the latter, CEP90 forms DISCO, which recruits CEP83
to root distal appendage formation. Consequently, depletion of CEP90 leads to mitotic
arrest, misaligned chromosomes, spindle pole fragmentation, and centriole duplication
defects [129,130]. Moreover, cells lacking CEP90 fail to remove CP110 and to recruit the
DAP proteins CEP83, FBF1, SCLT1, and CEP164 [42].
In humans, biallelic mutations in CEP90, also known as PIBF (OMIM 607532), have
been reported in seven independent families diagnosed with Joubert syndrome (MIM
617767) [131,132]. The affected individuals presented with cystic kidney disease, liver fibro-
sis, retinal dystrophy, and distinctive brain malformation. Morpholino oligomer-mediated
knockdown of the orthologous gene in a Xenopus model resulted in ciliogenesis defects
and impaired motility of multiciliated cells [131]. Mice carrying a homozygous deletion of
seven exons in Cep90 display cardiac looping defects, leading to early embryonic lethality.
Further studies indicate that embryos and MEFs lacking Cep90 fail to assemble distal
appendage-like structures, resulting in defective cilia assembly and disrupted Hedgehog
signaling [42]. Interestingly, mutations in genes encoding for the other two components
of the distal centriole complex, MNR/KIAA0753 (OMIM 617112), and OFD1 cause JBTS
(MIM 300804) or orofaciodigital syndrome (MIM 311200) [42].
5. Conclusions
DAPs are involved in multiple essential biological processes, including ciliogenesis,
cell cycle regulation, and DNA damage response. In addition, DAPs regulate cellular
responses such as cell proliferation, epithelial-to-mesenchymal transition, and apopto-
sis [15,18,97,109–111,116]. The present cell-based studies impressively demonstrated that
the hierarchically organized DAPs play a crucial role in the early phase of cilia formation.
They influence and regulate both the earliest initiative steps of primary vesicle formation,
the migration and anchoring of the centriole to the basement membrane, and the recruit-
ment and modification of the coordinating transport components, outside and inside the
cilium. In addition, there is a strong indication that the members of the DAP complex sig-
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nificantly influence the cell cycle regulation and thus also coordinate and regulate essential
extra-ciliary biological function.
Mutations in three genes encoding DAP proteins, namely, CEP83, CEP164, and SCLT1,
have been reported to be linked to heritable ciliopathies, such as NPHP and Joubert
syndromes. Genetic animal models of DAPs have been associated with defective cilia
formation and renal cyst development, but with an increased proliferation of renal epithelia
cell and dysregulated cell cycle activity. Although previous studies in various mammalian
cells and genetically modified animal models have highlighted the importance of DAPs in
the pathogenesis of NPHP-RC, their underlying pathomechanisms are largely unknown. To
what extent deficient DAP proteins affect ciliary-associated signal transduction pathways,
cellular or vesicular transport processes, or specific signaling molecules, including signaling
phosphoinositides, remains elusive.
Despite our improved understanding of the relevance of cilia, an ever-increasing level
of established ciliopathy-associated genes, and genetic diagnostics, the pathomechanisms
underlying NPHP-RC remain unclear, which has hindered the development of therapeutic
options. Accordingly, a specific treatment is virtually nonexistent. An improved under-
standing of the molecular consequences of perturbation in DAP functions may contribute
to the development of new treatment approaches.
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mechanisms underlying the role of the centriolar CEP164-TTBK2 complex in ciliopathies. Structure 2021, 6, 1–5. [CrossRef]
114. Hua, K.; Ferland, R.J. Primary Cilia Reconsidered in the Context of Ciliopathies: Extraciliary and Ciliary Functions of Cilia
Proteins Converge on a Polarity theme? BioEssays News Rev. Mol. Cell. Dev. Biol. 2018, 40, e1700132. [CrossRef] [PubMed]
115. Hua, K.; Ferland, R.J. Primary cilia proteins: Ciliary and extraciliary sites and functions. Cell. Mol. Life Sci. CMLS 2018, 75,
1521–1540. [CrossRef] [PubMed]
116. Sillibourne, J.E.; Hurbain, I.; Grand-Perret, T.; Goud, B.; Tran, P.; Bornens, M. Primary ciliogenesis requires the distal appendage
component Cep123. Biol. Open 2013, 2, 535–545. [CrossRef] [PubMed]
117. Das, A.; Guo, W. Rabs and the exocyst in ciliogenesis, tubulogenesis and beyond. Trends Cell Biol. 2011, 21, 383–386. [CrossRef]
118. Nachury, M.V.; Loktev, A.V.; Zhang, Q.; Westlake, C.J.; Peränen, J.; Merdes, A.; Slusarski, D.C.; Scheller, R.H.; Bazan, J.F.;
Sheffield, V.C. A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesis. Cell
2007, 129, 1201–1213. [CrossRef] [PubMed]
119. Tsang, W.Y.; Bossard, C.; Khanna, H.; Peränen, J.; Swaroop, A.; Malhotra, V.; Dynlacht, B.D. CP110 suppresses primary cilia
formation through its interaction with CEP290, a protein deficient in human ciliary disease. Dev. Cell 2008, 15, 187–197. [CrossRef]
[PubMed]
Int. J. Mol. Sci. 2021, 22, 12253 20 of 20
120. Hernandez-Hernandez, V.; Pravincumar, P.; Diaz-Font, A.; May-Simera, H.; Jenkins, D.; Knight, M.; Beales, P.L. Bardet-Biedl
syndrome proteins control the cilia length through regulation of actin polymerization. Hum. Mol. Genet. 2013, 22, 3858–3868.
[CrossRef]
121. Singla, V.; Romaguera-Ros, M.; Garcia-Verdugo, J.M.; Reiter, J.F. Ofd1, a human disease gene, regulates the length and distal
structure of centrioles. Dev. Cell 2010, 18, 410–424. [CrossRef]
122. Kim, J.C.; Badano, J.L.; Sibold, S.; Esmail, M.A.; Hill, J.; Hoskins, B.E.; Leitch, C.C.; Venner, K.; Ansley, S.J.; Ross, A.J. The
Bardet-Biedl protein BBS4 targets cargo to the pericentriolar region and is required for microtubule anchoring and cell cycle
progression. Nat. Genet. 2004, 36, 462–470. [CrossRef]
123. He, R.; Huang, N.; Bao, Y.; Zhou, H.; Teng, J.; Chen, J. LRRC45 is a centrosome linker component required for centrosome
cohesion. Cell Rep. 2013, 4, 1100–1107. [CrossRef]
124. Wei, Q.; Xu, Q.; Zhang, Y.; Li, Y.; Zhang, Q.; Hu, Z.; Harris, P.C.; Torres, V.E.; Ling, K.; Hu, J. Transition fibre protein FBF1 is
required for the ciliary entry of assembled intraflagellar transport complexes. Nat. Commun. 2013, 4, 2750. [CrossRef]
125. Wei, Q.; Ling, K.; Hu, J. The essential roles of transition fibers in the context of cilia. Curr. Opin. Cell Biol. 2015, 35, 98–105.
[CrossRef] [PubMed]
126. Kim, K.; Lee, K.; Rhee, K. CEP90 is required for the assembly and centrosomal accumulation of centriolar satellites, which is
essential for primary cilia formation. PLoS ONE 2012, 7, e48196. [CrossRef] [PubMed]
127. Kodani, A.; Timothy, W.Y.; Johnson, J.R.; Jayaraman, D.; Johnson, T.L.; Al-Gazali, L.; Sztriha, L.; Partlow, J.N.; Kim, H.; Krup, A.L.
Centriolar satellites assemble centrosomal microcephaly proteins to recruit CDK2 and promote centriole duplication. eLife 2015,
4, e07519. [CrossRef] [PubMed]
128. Kim, J.; Krishnaswami, S.R.; Gleeson, J.G. CEP290 interacts with the centriolar satellite component PCM-1 and is required for
Rab8 localization to the primary cilium. Hum. Mol. Genet. 2008, 17, 3796–3805. [CrossRef] [PubMed]
129. Hinchcliffe, E.H.; Li, C.; Thompson, E.A.; Maller, J.L.; Sluder, G. Requirement of Cdk2-cyclin E activity for repeated centrosome
reproduction in Xenopus egg extracts. Science 1999, 283, 851–854. [CrossRef]
130. Löffler, H.; Fechter, A.; Matuszewska, M.; Saffrich, R.; Mistrik, M.; Marhold, J.; Hornung, C.; Westermann, F.; Bartek, J.; Krämer, A.
Cep63 recruits Cdk1 to the centrosome: Implications for regulation of mitotic entry, centrosome amplification, and genome
maintenance. Cancer Res. 2011, 71, 2129–2139. [CrossRef]
131. Ott, T.; Kaufmann, L.; Granzow, M.; Hinderhofer, K.; Bartram, C.R.; Theiß, S.; Paramasivam, N.; Schulz, A.; Moog, U.; Blum, M.
The Frog Xenopus as a Model to Study Joubert Syndrome: The Case of a Human Patient with Compound Heterozygous Variants
in PIBF1. Front. Physiol. 2019, 10, 134. [CrossRef]
132. Wheway, G.; Schmidts, M.; Mans, D.A.; Szymanska, K.; Nguyen, T.M.T.; Racher, H.; Phelps, I.G.; Toedt, G.; Kennedy, J.;
Wunderlich, K.A.; et al. An siRNA-based functional genomics screen for the identification of regulators of ciliogenesis and
ciliopathy genes. Nat. Cell Biol. 2015, 17, 1074–1087. [CrossRef] [PubMed]
